Double Blind Trial of L-Dopa in Chronic Schizophrenia-Reference-Cited by-同舟云学术

Double Blind Trial of L-Dopa in Chronic Schizophrenia

Published:1975-12 Issue:4 Volume:9 Page:269-271
ISSN:0004-8674
Container-title:Australian & New Zealand Journal of Psychiatry
language:en
Short-container-title:Aust N Z J Psychiatry

Author:

Buchanan F. H.¹,Parton R. V.²,Warren J. W.²,Baker E. P.²

Affiliation:

1. John Edis Hospital, New Town, Tasmania

2. Royal Derwent Hospital, New Norfolk, Tasmania

Abstract

A double blind study in 28 patients with chronic schizophrenia was carried out comparing L-dopa (up to 1250 mgm daily) with placebo (both groups continuing to receive regular neuroleptic medication) over a six week period. Assessments by the psychiatrists and psychologist using Rockland and Pollin Rating Scale showed differential improvement of insignificant proportions but the nurse's ratings showed clearly significant improvement in the subject group.

Publisher

SAGE Publications

Subject

Psychiatry and Mental health,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.3109/00048677509159861

Reference6 articles.

1. The effect of haloperidol on the urinary excretion of dopamine, homovanillic and vanilmandelic acids in schizophrenics

2. EFFECTS OF L-DOPA ON PHARMACOLOGICAL PARKINSONISM

3. THREE CASES OF SCHIZOPHRENIA TREATED WITH L-DOPA

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review;Journal of Psychiatric Research;2019-01

2. Enhanced Cortical Dopamine Output and Antipsychotic-like Effect of Raclopride with Adjunctive Low-Dose L-dopa;Biological Psychiatry;2005-08

3. A meta-analysis of the response to chronic l-dopa in patients with schizophrenia: therapeutic and heuristic implications;Psychopharmacology;2004-02-01

4. Données biologiques de la schizophrénie;EMC - Psychiatrie;2004-01

5. Pharmacotherapy for refractory schizophrenia patients;Expert Review of Neurotherapeutics;2003-05